Výsledky vyhledávání - "Amit Y Jadhav"

Akademický článek

Clinical features and treatment outcomes of cardiomyopathy in Indian patients: An observational, retrospective study in tertiary care teaching institute

Autor: Anil R Jawahirani, Deepak Jeswani, Dilip Kshirsagar, Rajnish M Dhediya, Amit Y Jadhav

Publikováno v: Heart India, Vol 9, Iss 1, Pp 60-65 (2021)

Objective: Cardiomyopathy is defined as a heterogeneous group of diseases of the myocardium, is a transient reversible, but potentially life-threatening condition. The natural history, management pattern, and outcome of cardiomyopathy are not clear i

Externí odkaz: https://doaj.org/article/49e9f84e41c44eb0a4e8011b177cf6c8

Zobrazit plný text záznamu

Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India

Autor: Prahlad Prabhudesai, Bhanu P Singh, Gyanendra Agrawal, Ashok Kumar Singh, Amit Y Jadhav, Saurabh R Patil, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate

Publikováno v: Cureus.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::edd7ed0c81d7f6386d4c30211ad06fa8
https://doi.org/10.7759/cureus.34825

Zobrazit plný text záznamu

The Effectiveness of an Oral Fixed-Dose Combination of Netupitant and Palonosetron (NEPA) in Patients With Multiple Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Observational Indian Study

Autor: Bharat Vaswani, Palanki S Dattatreya, Hanmant Barkate, Sagar B Bhagat, Saiprasad Patil, Amit Y Jadhav

Publikováno v: Cureus. 14(9)

Background Female gender, young age, first chemotherapy cycle, and low alcohol intake have all been linked to an increased risk of nausea and vomiting from chemotherapy. We intended to see if netupitant and palonosetron (NEPA) could prevent chemother

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::068b3490bc24da2a6dd6d5c89ea0d28b
https://pubmed.ncbi.nlm.nih.gov/36259011

Zobrazit plný text záznamu

Effectiveness of NEPA, an oral fixed-dose combination of NEtupitant and PAlonosetron in the prevention of chemotherapy-induced nausea-vomiting in patient receiving highly emetogenic chemotherapy regimens

Autor: Amit Y Jadhav, Sudeep Gupta, Ghanashyam Biswas, Chandrakanth MV, Palanki Satya Dattatreya, Boben Thomas, Sumant Gupta, Sagar B Bhagat, Saiprasad Patil, Hanmant B Barkate

Publikováno v: Journal of Clinical Oncology. 40:e24090-e24090

e24090 Background: Patients receiving Highly Emetogenic chemotherapy (HEC) are > 90% risk of nausea-vomiting due to the drug's emetogenic potential and patient-related factors such as young age, female gender, low/no alcohol, H/O morning sickness and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7cfbab9b0192842f5fa2a2f22a52298b
https://doi.org/10.1200/jco.2022.40.16_suppl.e24090

Zobrazit plný text záznamu

Role of Tenecteplase in management of acute ischemic stroke: a knowledge, attitude, and practice survey among Indian neurologists

Autor: Amit Y. Jadhav, Onkar C Swami, Rajnish M. Dhediya

Publikováno v: International Journal of Research in Medical Sciences. 9:724

Background: Tenecteplase, a third generation tissue plasminogen activator has important place in the thrombolytic therapy in acute ischemic stroke. The objective of present study was to understand the knowledge, attitude and practice (KAP) towards th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::889136c1c35c9c1e4195d0b721cdd228
https://doi.org/10.18203/2320-6012.ijrms20210485

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání